Simris Group AB’s wholly owned subsidiary, Simris Biologics GmbH, today announced important progress in its ongoing preclinical study with Nuvisan, a leading European contract research and development ...

Greetings. Welcome to Sutro Biopharma R&D Day 2025 Conference Call. [Operator Instructions] Please note, this conference is being recorded. I will now turn the conference over to Jane Chung, CEO.

- Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for its initial dual-payload candidate, STRO-227 - - ...

Your faction's emergence has deepened the division within the ADC just months after the opposition coalition took over the party. What exactly led to the split, and do you believe it was unavoidable?

This approval builds on BioDlink's earlier success with Lepu Biopharma's ADC program that achieved 100% first-pass success across technology transfer, Process Performance Qualification (PPQ), and ...

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format ...

(MENAFN- GlobeNewsWire - Nasdaq) - Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for its initial ...

The deadline for families wishing to apply for assistance through the Temple Police Department’s Blue Santa program is 5 p.m. on Friday, Nov. 14.

House Speaker Mike Johnson discusses if SNAP is serving its purpose amid the government shutdown on 'The Will Cain Show.' Woman divorced at 28 starts dating again—unprepared for realization Chrysler ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...